Ned Atiyah
Data Analyst/PhD Student

Profile

Biography

Ned works part time as a data analyst for the ECSG Research Group. In this role, he uses clinical and laboratory data along with routine  datasets, such as Hospital Episode Statistics, to produce routine reports and for research purposes.

Ned is a NIHR Leeds BRC PhD student based within the Epidemiology and Cancer Statistics Group (ECSG) and the Leeds Institute for Data Analytics (LIDA). His research focuses on new treatments for haematological malignancies, including CAR-T therapy. Using clinical, genomic and digital pathology data, Ned aims to identify predictors of treatment outcomes. 

Qualifications

BSc (Hons) Biomedical Sciences (University of York, 2021)

MA Public Health (University of York)

Supervisors

Prof David Westhead

Prof Alex Smith

Prof Eve Roman

Funding

NIHR Leeds BRC

Research

Overview

• Computational analysis
• Bioinformatics
• Analysis of real-world data
• Survival analysis

Projects

York/Leeds BRC Haematology: Using data and computational methods to understand the effects of multi-morbidity and social factors on haematological cancer incidence and outcomes.

Research group(s)

Epidemiology and Cancer Statistics Group (ECSG)

NIHR Leeds BRC - Haematology

Publications

Selected publications

613. ACUTE LYMPHOBLASTIC LEUKEMIAS: THERAPIES EXCLUDING ALLOGENEIC TRANSPLANTATION: A UK Intention to Treat Analysis of
Brexucabtagene Autoleucel for Relapsed or Refractory Adult Acute Lymphoblastic Leukaemia Following 1 Year of Therapy Access

Anna Z Castleton, Michelle Lannon, Ned Atiyah, Alex Smith, Lindsay George, Sridhar Chaganti, Eleni Tholouli, Pakhshan Farshi, Nicholas
Cunningham, Claire Arnold, Nick Morley, Phillipa Kelsey, Prudence Hardefeldt, Katja Kimberger, Manish Jain, Maeve O'Reilly, Richard Burt, Tobias Menne, Ahmed Abdulgawad, Katherine Hodby, Aniruddha Dayama, David Irvine, Anne Louise Latif, Deborah Susan Richardson, Mariam Amer, Ram Malladi, James Aries, Seda Cakmak, Johannes De Vos, Gerrardo Errico, Emma Nicholson, Kirsty Sharplin, Andrew Peniket, Bela Patel Wrench, Anthony Moorman, Clare Rowntree, David Marks, Adele Fielding, Deborah Yallop
https://doi.org/10.1182/blood-2024-199287

Abstracts

RUXOLITINIB IMPROVED SURVIVAL IN MYELOFIBROSIS PATIENTS WITH 1 OR MORE HIGH MOLECULAR RISK  MUTATIONS
Chun Teh,  Manish Jain,  Catherine Cargo,  Ned Atiyah, Timothy Bagguley, Alexandra Smith